ReShape Lifesciences (Formally known as EnteroMedics)

280 articles about ReShape Lifesciences (Formally known as EnteroMedics)

• EnteroMedics Urges Shareholders To Vote For Proposed Amendments At October 19 Special Shareholder Meeting

  10/14/2016

• EnteroMedics Highlights Recent Achievements Ahead Of Special Shareholder Meeting

  10/11/2016

• EnteroMedics Announces Partner's National VA Contract Includes vBloc Therapy For The Treatment Of Obesity

  10/5/2016

• EnteroMedics Announces Appointment Of Dan Gladney As Chairman Of The Board Of Directors

  9/27/2016

• EnteroMedics To Present At The Ladenburg Thalmann Healthcare Conference

  9/21/2016

• EnteroMedics Announces Receipt Of Notice Of Intention To Grant European Patent Covering Safety Features Of vBloc Therapy Strengthening Company's Neuromodulation Intellectual Property Portfolio Of More Than 70 Patents Worldwide

  9/19/2016

• vBloc Institute Demonstrates Positive Clinical Success In Patients Struggling With Weight Loss As Compared To Pivotal FDA Trial With EnteroMedics VBloc Therapy In Combination With VBloc Achieve Program

  9/13/2016

• EnteroMedics Hires Former Galil Medical Exec as New CFO

  9/7/2016

• EnteroMedics Announces Appointment Of Gary Blackford To Its Board Of Directors

  8/17/2016

• EnteroMedics Announces Publication Of 24 Month ReCharge Clinical Study Data In Obesity Surgery

  8/15/2016

• EnteroMedics Reports Second Quarter 2016 Financial Results

  8/4/2016

• EnteroMedics Highlights Recent Patient Success With vBloc Therapy In Combination With vBloc Achieve Program

  6/29/2016

• EnteroMedics Announces First-Of-Its-Kind Procedure With vBloc Therapy Used As Adjunctive Rescue Treatment For Failed Gastric Sleeve In Patients With Obesity

  6/1/2016

• EnteroMedics To Host vBloc Commercialization Update Conference Call

  5/23/2016

• EnteroMedics Reports First Quarter 2016 Financial Results

  5/6/2016

• EnteroMedics Announces Closing Of $6.25 Million Third Tranche Of Previously-Announced Convertible Notes Offering

  5/3/2016

• EnteroMedics Forges Pact with VA Distributor for Maestro Anti-Obesity Device

  5/2/2016

• EnteroMedics Announces Publication Of Results Showing Significantly Greater Weight Loss In VBloc Patients With Moderate Obesity

  4/5/2016

• EnteroMedics To Present At The 28th Annual ROTH Conference

  3/9/2016

• EnteroMedics Reports Fourth Quarter 2015 Financial Results

  2/17/2016